Quadria-backed HealthQuad invests in patient monitoring platform LifeSigns

Quadria-backed HealthQuad invests in patient monitoring platform LifeSigns

Photo by Hush Naidoo on Unsplash

HealthQuad, the growth venture arm of Quadria Group focused on backing new-age healthcare models, has invested in LifeSigns, an India-based AI-powered remote patient monitoring platform.

Financial details of the transaction were not disclosed.

The investment aligns with HealthQuad’s thesis around healthcare innovation, as the sector shifts from episodic and reactive treatment toward continuous and predictive care, the company said in a statement.

As health systems globally grapple with rising demand beyond major urban centres, workforce shortages, and mounting cost pressures, continuous patient monitoring and early intervention are becoming increasingly critical. LifeSigns leverages AI to detect early signs of patient deterioration, support timely clinical decisions, and improve healthcare outcomes.

The company has expanded deployments across tier-2 cities in India, supported by an occupancy-based pricing model and a scalable platform aimed at improving access to quality healthcare in underserved markets.

Through Quadria’s healthcare ecosystem, the partnership will focus on two priorities for LifeSigns: expanding into Southeast Asia and the GCC, and strengthening its AI-driven technology stack through selective integrations.

HealthQuad Fund III, the successor to HealthQuad Fund I and II, targets category-defining healthcare companies building scalable solutions for large, real-world healthcare challenges.

“Healthcare today is built on periodic observation, while risk is real-time. The future lies in continuous monitoring led by predictive intelligence. LifeSigns is building that layer to detect deterioration early and enable timely intervention, which can significantly improve outcomes and reduce healthcare costs at scale. This is a globally relevant model and where the next wave of healthcare will be built. With access to Quadria’s ecosystem, we are well-positioned to help Hari and the LifeSigns team scale across global markets,” said Rahul Agarwal, Partner, HealthQuad.

LifeSigns has developed a US FDA-approved continuous monitoring platform integrating a medical-grade wearable, cloud dashboard, and predictive AI engine. The platform is used across ambulances, emergency rooms, ICUs, hospital wards, and home-care settings.

Founded in 2016, HealthQuad manages over $350 million in assets and backs healthcare startups through Quadria Group’s broader healthcare investment ecosystem.

Edited by: Padma Priya

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter


This is your last free story for the month. Register to continue reading our content